Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433738/0/images/tooltip-triangle.png. Accessed 02 May 2024.
Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/0/images/tooltip-triangle.png. Accessed May 2, 2024.
Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/0/images/tooltip-triangle.png
Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/0/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review
ID - 433738
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/0/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -